Esta tradução está a ser preparada. Entretanto, mostramos temporariamente a versão original em inglês.
Negócios · 12/01/20221 min de leitura
Determination of Regulatory Review Period for Purposes of Patent Extension; ENHERTU; Correction
Tradução automática local · Idioma original da fonte
Resumo
The Food and Drug Administration (FDA or the Agency) published a notice in the Federal Register of November 1, 2021, for the determination of a regulatory review period for purposes of patent extension for the human biological product, ENHERTU. This document corrects that notice by adjusting the applicable regulatory review period for the testing phase and approval phase of the product, ENHERTU.
Idioma original da fonte: Federal Register — Food and Drug AdministrationAbrir o comunicado original →